IGFBP4 anticorps (AA 22-258)
-
- Antigène Voir toutes IGFBP4 Anticorps
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Épitope
- AA 22-258
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp IGFBP4 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Fonction
- Monoclonal Antibody to Insulin Like Growth Factor Binding Protein 4 (IGFBP4)
- Séquence
- MGHHHHHHSG SEF-DEAIHCPPC SEEKLARCRP PVGCEELVRE PGCGCCATCA LGLGMPCGVY TPRCGSGLRC YPPRGVEKPL HTLMHGQGVC MELAEIEAIQ ESLQPSDKDE GDHPNNSFSP CSAHDRRCLQ KHFAKIRDRS TSGGKMKVNG APREDARPVP QGSCQSELHR ALERLAASQS RTHEDLYIIP IPNCDRNGNF HPKQCHPALD GQRGKCWCVD RKTGVKLPGG LEPKGELDCH QLADSFRE
- Specificité
- The antibody is a mouse monoclonal antibody raised against IGFBP4. It has been selected for its ability to recognize IGFBP4 in immunohistochemical staining and western blotting.
- Réactivité croisée
- Souris, Porc, Rat
- Purification
- Protein A + Protein G affinity chromatography
- Immunogène
- Recombinant Insulin Like Growth Factor Binding Protein 4 (IGFBP4) corresdonding to Asp22~Glu258 with N-terminal His Tag
- Clone
- A3
- Isotype
- IgG1 kappa
- Top Product
- Discover our top product IGFBP4 Anticorps primaire
-
-
- Indications d'application
-
Western blotting: 0.5-2 μg/mL
Immunohistochemistry: 5-20 μg/mL
Immunocytochemistry: 5-20 μg/mL
Optimal working dilutions must be determined by end user.
- Commentaires
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
- Date de péremption
- 24 months
-
- Antigène
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
- Autre désignation
- Insulin Like Growth Factor Binding Protein 4 (IGFBP4 Produits)
- Synonymes
- anticorps IGFBP4, anticorps igfbp4, anticorps BP-4, anticorps HT29-IGFBP, anticorps IBP4, anticorps IGFBP-4, anticorps AI875747, anticorps Deb2, anticorps IGF-BP4, anticorps IBP-4, anticorps insulin like growth factor binding protein 4, anticorps insulin-like growth factor-binding protein 4, anticorps insulin-like growth factor binding protein 4, anticorps IGFBP4, anticorps LOC100136305, anticorps LOC100194498, anticorps igfbp4, anticorps Igfbp4
- Sujet
- BP4, HT29-IGFBP, IBP4
- Pathways
- Signalisation WNT, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
-